Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)
Stopped early · Phase 2
Conditions studied: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, CLL, SLL
In brief
This study will assess the efficacy, safety and pharmacodynamic markers of the study drug, A6, in patients with CLL and small lymphocytic lymphoma (SLL).
Key facts
- Study ID
- NCT02046928
- Run by
- Ångstrom Pharmaceuticals
- People needed
- 5
- Starts
- 2014-02-01
- Expected to finish
- 2016-03-01
- Last updated by the study team
- 2016-07-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Confirmed diagnosis of CLL or SLL based on IWCLL Criteria
- Measurable or evaluable disease based on IWCLL criteria
- Previously untreated patients who have been counseled on approved alternative therapeutic options. Not a candidate for fludarabine/cyclophosphamide/rituximab (FCR) or has preference to not receive chemotherapy.
- Eastern Cooperative Oncology Group (ECOG) status of 0-2.
- Adequate bone marrow, renal, liver, cardiac and pulmonary function.
- Life expectancy of greater than or equal to 6 months.
You may not qualify if…
- Receipt of other cancer therapy, immunomodulatory drug therapy or immunosuppressive therapy within 4 weeks prior to 1st dose.
- Receipt of corticosteroids > 20 mg/day within 4 weeks prior to1st dose
- Major surgery or radiation within 4 weeks prior to 1st dose
- Presence of uncontrolled infection requiring systemic therapy
- Active second malignancy other than non-melanoma skin cancer
- Uncontrolled autoimmune anemia or thrombocytopenia
- Receipt of any investigational agent within 4 weeks prior to 1st dose
- Pregnant or lactating female
- Any severe, acute or chronic medical or psychiatric condition, or lab abnormality that may increase the risk associated with trial participation, study drug administration or interfere with informed consent process or compliance with requirements of the trial.
Where it is running
- Moores Cancer Center, UCSD — La Jolla, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.